Cancer Clinical Trials During COVID-19

April/May 2020

Clinical Trials During COVID-19

Despite COVID-19’s impact on medical care, researchers are working hard to keep clinical trials open, recruiting, and on time. The FDA and individual hospitals have established guidelines and policies to help trial teams accomplish this. Pharmaceutical and biotech companies are also making changes to work toward progress. Below you will find information about new policies and guidelines.

If you are on a clinical trial or considering a clinical trial, talk to your doctor or the clinical trial team to learn how your hospital and your trial may be affected. For all COVID-19 related information, visit the COVID-19 & Breast Cancer main page.

Impact of COVID-19 on Cancer Clinical Trials 

FDA Guidance on Clinical Trials

Changes to Clinical Trials by Sponsors and Research Sites

 

Leave a Reply